Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Smith & Nephew Snats ( (SNN) ).
Smith & Nephew plc announced the purchase of ordinary shares by its Chief Financial Officer, John Rogers, on December 19, 2024. This transaction, conducted on the London Stock Exchange, involved 71,920 shares purchased at prices around £9.72 per share, reflecting ongoing investment by key company leadership in the company’s stock. This move underscores confidence in the company’s strategic direction and potential for growth, likely having implications for investor sentiment and market positioning.
More about Smith & Nephew Snats
Smith & Nephew plc is a global medical technology company headquartered in Watford, England. The company specializes in advanced medical devices for wound management, orthopedics, and sports medicine, with a focus on improving patient outcomes across various healthcare settings.
YTD Price Performance: -6.63%
Average Trading Volume: 793,693
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $10.64B
Learn more about SNN stock on TipRanks’ Stock Analysis page.
